| Literature DB >> 32518604 |
Lucian Iorga1, Radu Dragos Marcu1,2, Camelia Cristina Diaconu2,3, Ana Maria Alexandra Stanescu2, Anca Pantea Stoian2, Dan Liviu Dorel Mischianu1,2, Mihaela Surcel4, Simona Bungau5, Traian Constantin2,6, Daniel Boda7, Laszlo Fekete8, Ovidiu Gabriel Bratu1,2.
Abstract
Penile carcinoma is a relatively frequent health issue in the developing countries such as Africa, Asia and South America, usually affecting men aged between 50 and 70 years. It is a highly treatable disease in its early stages, but has serious physical and psychological consequences. Usually, penile carcinoma is located in the penile glans, in approximately half the cases, with the most frequent histological type being squamous cell carcinoma with its microscopic subtypes. A large number of risk factors have been reported for this disease, having a multifactorial etiology, HPV infection being one of the most important factors involved in its appearance. Out of the HPV DNA positive genital cancers HPV-16 is the most frequently found type in men, followed by HPV-18. The evolution of penile cancer includes two independent carcinogenic pathways, related or unrelated to HPV infection. There is limited data available in literature regarding HPV-related neoplasia, as well as on the efficacy of vaccination in men, with studies still ongoing.Entities:
Keywords: HPV infection; penile carcinoma; risk factors; squamous cell carcinoma; vaccination
Year: 2019 PMID: 32518604 PMCID: PMC7273896 DOI: 10.3892/etm.2019.8181
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447